Abu Dhabi Development, a holding company, agreed to acquire Acino, a Swiss pharmaceutical company, from private equity firms Nordic Capital and Avista Capital Partners. Financial terms were not disclosed. Acino is committed to advancing the development of healthcare by enhancing access to high-quality medicines that patients and governments can trust and value, and ADQ’s support will accelerate this ambition. Having built a solid reputation as a leading provider of advanced pharmaceutical solutions in emerging markets, we are excited about the opportunity for business transformation and commercial growth potential as Acino joins ADQ’s healthcare and pharma portfolio," Steffen Saltofte, Acino CEO.